|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2011-4-6
|
|
pubmed:abstractText |
Antimicrobial and antimotility agents are not recommended for the treatment of Shiga toxin-producing Escherichia coli O157 infection. In our study, many persons with Shiga toxin-producing E. coli O157 infection took antimicrobial (62%) and antimotility agents (32%); 43 (29%) of 146 reported commencing antimicrobial treatment after laboratory confirmation. Efforts are needed to promote practice guidelines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1130-2
|
|
pubmed:meshHeading |
pubmed-meshheading:21467017-Adolescent,
pubmed-meshheading:21467017-Adult,
pubmed-meshheading:21467017-Anti-Bacterial Agents,
pubmed-meshheading:21467017-Case-Control Studies,
pubmed-meshheading:21467017-Child,
pubmed-meshheading:21467017-Child, Preschool,
pubmed-meshheading:21467017-Diphenoxylate,
pubmed-meshheading:21467017-Escherichia coli Infections,
pubmed-meshheading:21467017-Escherichia coli O157,
pubmed-meshheading:21467017-Hemolytic-Uremic Syndrome,
pubmed-meshheading:21467017-Humans,
pubmed-meshheading:21467017-Loperamide,
pubmed-meshheading:21467017-Parasympatholytics,
pubmed-meshheading:21467017-Physician's Practice Patterns,
pubmed-meshheading:21467017-Population Surveillance,
pubmed-meshheading:21467017-Shiga Toxins,
pubmed-meshheading:21467017-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.
|
|
pubmed:affiliation |
Emory University, GA, USA.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
